Anixa Biosciences Inc (ANIX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 10/31
| 10-2005 | 10-2004 | 10-2003 | 10-2002 | 10-2001 | |
| Sales | 440 | 495 | 244 | 5,187 | 1,691 |
| Cost of Goods | 720 | 176 | 176 | 1,871 | 698 |
| Gross Profit | -280 | 318 | 68 | 3,316 | 993 |
| Operating Expenses | 4,906 | 3,860 | 3,363 | 7,495 | 5,295 |
| Operating Income | -4,466 | -3,365 | -3,119 | -3,309 | -3,604 |
| Other Income | 15 | 4 | 5 | 24 | 32 |
| Pre-tax Income | -4,451 | -3,361 | -3,114 | -3,285 | -3,572 |
| Net Income Continuous | -4,451 | -3,361 | -3,114 | -3,285 | -3,572 |
| Net Income | $-4,451 | $-3,361 | $-3,114 | $-3,285 | $-3,572 |
| EPS Basic Total Ops | -1.25 | -1.00 | -1.00 | -1.25 | -1.50 |
| EPS Basic Continuous Ops | -1.26 | -1.01 | -1.04 | -1.21 | -1.38 |
| EPS Diluted Total Ops | -1.25 | -1.00 | -1.00 | -1.25 | -1.50 |
| EPS Diluted Continuous Ops | -1.26 | -1.01 | -1.04 | -1.21 | -1.38 |
| EBITDA(a) | $-4,451 | $-3,348 | $-3,086 | $-3,222 | $-3,438 |